Skip to content
Equity Capital Market
  • Start Here
  • Research
    • LPTH case study
    • PLUG case study
    • STDN case study
  • Latest
  • Stock Market
  • Market Education
  • Capital Markets
  • Federal Reserve & Rates
  • About
  • Contact

biomarker

McKesson to Buy Precision Medicine Group for $2.25B

September 12, 2026August 25, 2026 by Bruno
McKesson to Buy Precision Medicine Group for $2.25B

McKesson unveiled a $2.25B deal for Precision Medicine Group, doubling down on its fastest-growing segment: Oncology & Multispecialty.

Categories Stock Market Tags biomarker, capital markets, mckesson, oncology services, precision medicine group

Explore ECMSource

New here? Begin with our guide to the site, then explore the subjects that match what you want to understand.

  • Start Here
  • Market Education
  • Stock Market
  • Capital Markets
  • Federal Reserve & Rates

Recent Posts

  • Skyworks Completes $22B Qorvo Merger to Form RF Giant
  • C.H. Robinson to Buy RXO in $5.8B Cash and Stock Deal
  • Fallen Angels vs. Rising Stars: How Bond Migrations Work
  • Minerals Tech Prices $400M Senior Notes Due 2032 at 7.500%
  • Cal-Maine Foods Swings to Q1 Loss as Egg Prices Fall 59%
© 2026 Equity Capital Market • Built with GeneratePress